Related Experiment Video
Updated: Aug 6, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
A Case of Idiopathic Hypocupric Myeloneuropathy
Srivatsav Addepalli1, Satish Nirhale, Shalesh Rohatgi
1Department of Neurology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India.
Abstract:
Copper deficiency myeloneuropathy is a rare but treatable cause of noncompressive myelopathy that can mimic subacutecombined degeneration (SACD) due to vitamin B12 deficiency. Risk factors include gastrointestinal surgery, zinc overload, and malabsorption syndromes; however, no etiology is identified in up to 20% of cases. We report a 21-year-old female with no significant comorbidities, presenting with progressive gait difficulty, lower limb stiffness, imbalance, and unaware footwear slippage over 1 year. Neurological examination, laboratory tests, magnetic resonance imaging (MRI), and nerve conduction studies were performed. Examination revealed lower limb hypertonia, power 4+/5, exaggerated deep tendon reflexes in upper and lower limbs with absent ankle jerks, extensor plantars, and positive Romberg's sign. MRI showed cervical cord T2 hyperintensity with an "inverted V sign." Hemoglobin was 10.4 g/dL with MCV 116 fL, but vitamin B12 was >2000 pg/mL. Serum copper was low (24 mg/dL) and serum zinc was elevated (224.8 mg/dL). Nerve conduction study demonstrated symmetrical sensory axonal neuropathy. The patient was started on oral copper 8 mg/day. This case highlights the importance of considering copper deficiency myeloneuropathy even in the absence of typical risk factors or B12 deficiency. Early recognition and copper supplementation may prevent irreversible neurological damage.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Multiple Sclerosis l: Introduction
Huntington Disease l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Atypical Pneumonia